Autolus Therapeutics plc

NasdaqGS:AUTL 株式レポート

時価総額：US$955.3m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Autolus Therapeutics マネジメント

マネジメント 基準チェック /44

Autolus Therapeutics'の CEO はChris Itinで、 Mar2016年に任命され、 の在任期間は 8.25年です。 の年間総報酬は$ 2.45Mで、 22.5%給与と77.5%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.4%を直接所有しており、その価値は$ 4.59M 。経営陣と取締役会の平均在任期間はそれぞれ2.7年と4.3年です。

主要情報

Chris Itin

最高経営責任者

US$2.4m

報酬総額

CEO給与比率22.5%
CEO在任期間8.4yrs
CEOの所有権0.4%
経営陣の平均在職期間2.8yrs
取締役会の平均在任期間4.5yrs

経営陣の近況

Recent updates

Is Autolus Therapeutics (NASDAQ:AUTL) Using Debt Sensibly?

Aug 15
Is Autolus Therapeutics (NASDAQ:AUTL) Using Debt Sensibly?

Autolus Therapeutics: Major Inflection Point On The Horizon

Jul 31

Autolus Therapeutics: Trading Like Their Products Are Not Valuable, Which Is An Opportunity

May 14

We're Hopeful That Autolus Therapeutics (NASDAQ:AUTL) Will Use Its Cash Wisely

Nov 06
We're Hopeful That Autolus Therapeutics (NASDAQ:AUTL) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Autolus Therapeutics' (NASDAQ:AUTL) Cash Burn Situation

Jun 26
Here's Why We're Not Too Worried About Autolus Therapeutics' (NASDAQ:AUTL) Cash Burn Situation

We Think Autolus Therapeutics (NASDAQ:AUTL) Can Afford To Drive Business Growth

Mar 09
We Think Autolus Therapeutics (NASDAQ:AUTL) Can Afford To Drive Business Growth

Is Autolus Therapeutics plc (NASDAQ:AUTL) Worth US$1.9 Based On Its Intrinsic Value?

Dec 12
Is Autolus Therapeutics plc (NASDAQ:AUTL) Worth US$1.9 Based On Its Intrinsic Value?

Autolus stock rises as Moderna uses option to license targeting technology for mRNA therapy

Oct 12

Autolus Therapeutics: Overlooked CAR-T Player With Key Catalysts Approaching

Aug 17

Autolus Therapeutics Q2 2022 Earnings Preview

Aug 03

Here's Why We're Not Too Worried About Autolus Therapeutics' (NASDAQ:AUTL) Cash Burn Situation

Apr 19
Here's Why We're Not Too Worried About Autolus Therapeutics' (NASDAQ:AUTL) Cash Burn Situation

We Think Autolus Therapeutics (NASDAQ:AUTL) Needs To Drive Business Growth Carefully

Dec 15
We Think Autolus Therapeutics (NASDAQ:AUTL) Needs To Drive Business Growth Carefully

Autolus: Developing Better CAR-T In Refractory ALL

Jul 20

CEO報酬分析

Autolus Therapeutics の収益と比較して、Chris Itin の報酬はどのように変化したか？
日付総報酬給与会社業績
Jun 30 2024n/an/a

-US$234m

Mar 31 2024n/an/a

-US$221m

Dec 31 2023US$2mUS$551k

-US$208m

Sep 30 2023n/an/a

-US$158m

Jun 30 2023n/an/a

-US$155m

Mar 31 2023n/an/a

-US$152m

Dec 31 2022US$3mUS$502k

-US$149m

Sep 30 2022n/an/a

-US$164m

Jun 30 2022n/an/a

-US$155m

Mar 31 2022n/an/a

-US$146m

Dec 31 2021US$3mUS$543k

-US$142m

Sep 30 2021n/an/a

-US$143m

Jun 30 2021n/an/a

-US$147m

Mar 31 2021n/an/a

-US$145m

Dec 31 2020US$4mUS$522k

-US$142m

Sep 30 2020n/an/a

-US$140m

Jun 30 2020n/an/a

-US$130m

Mar 31 2020n/an/a

-US$127m

Dec 31 2019US$5mUS$517k

-US$124m

Sep 30 2019n/an/a

-US$104m

Jun 30 2019n/an/a

-US$89m

Mar 31 2019n/an/a

-US$68m

Dec 31 2018n/an/a

-US$58m

Sep 30 2018US$2mUS$403k

-US$45m

報酬と市場: Chrisの 総報酬 ($USD 2.45M ) は、 US市場 ($USD 3.21M ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Chrisの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Chris Itin (60 yo)

8.4yrs

在職期間

US$2,449,092

報酬

Dr. Christian Martin Itin, also known as Chris, Ph D., has been the Chief Executive Officer of Autolus Therapeutics Plc. (Former Name: Autolus Limited) since March 3, 2016.Dr. Itin has been Director of Au...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Christian Itin
CEO & Director8.4yrsUS$2.45m0.40%
$ 3.8m
Martin Pule
Founder10yrsデータなし0.26%
$ 2.5m
Robert Dolski
Senior VP & CFOless than a yearデータなしデータなし
Christopher Vann
Senior VP & COO7.8yrsデータなし0.042%
$ 402.9k
David Brochu
Senior VP & Chief Technical Officer3.6yrsデータなし0%
$ 0
Alexander Swan
Senior VP & Chief Human Resources Officer2.8yrsデータなし0%
$ 0
Brent Rice
Senior VPno dataデータなし0.0035%
$ 33.7k
Olivia Manser
Director of Investor Relationsno dataデータなしデータなし
Alex Driggs
Senior VP of Legal Affairs & General Counsel and Secretary2.8yrsデータなしデータなし
Chris Williams
Senior VP & Chief Business Development Officerless than a yearデータなし0.0031%
$ 29.4k
Miranda Neville
Senior Vice President of Project Management1.1yrsデータなしデータなし
Veronica Hersberger
Senior Vice President of Medical Affairs1.6yrsデータなしデータなし

2.8yrs

平均在職期間

58.5yo

平均年齢

経験豊富な経営陣: AUTLの経営陣は 経験豊富 であると考えられます ( 2.7年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Christian Itin
CEO & Director9.8yrsUS$2.45m0.40%
$ 3.8m
William Young
Independent Non-Executive Director2.8yrsUS$224.14k0%
$ 0
Michael Bonney
Chairman of the Boardless than a yearデータなしデータなし
Cynthia Butitta
Independent Non-Executive Director6.4yrsUS$209.89k0.0038%
$ 35.9k
John Berriman
Independent Non-Executive Director10yrsUS$207.98k0.051%
$ 489.6k
Martin Murphy
Independent Non-Executive Director9.9yrsUS$201.77k0%
$ 0
Joseph Anderson
Independent Non-Executive Director8.5yrsUS$207.98k0%
$ 0
Linda Bain
Independent Non-Executive Director6.2yrsUS$216.11k0%
$ 0
Robert Azelby
Non-Executive Directorless than a yearデータなし0%
$ 0
Robert Iannone
Non-Executive Director1.2yrsUS$171.92k0%
$ 0
Ravi Rao
Non-Executive Directorless than a yearデータなしデータなし
Elisabeth Leiderman
Non-Executive Directorless than a yearUS$16.22k0%
$ 0

4.5yrs

平均在職期間

58.5yo

平均年齢

経験豊富なボード: AUTLの 取締役会 は 経験豊富 であると考えられます ( 4.3年の平均在任期間)。